Clinical proteomics identifies urinary CD14 as a potential biomarker for diagnosis of stable coronary artery disease

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Lee, Min Yi ^a,b   Huang, Chun Hao ^a   Kuo, Chao Jen ^a,c   Lin, Chen Lung Steve ^a,d   Lai, Wen Ter ^d   Chiou, Shyh Horng ^a,c,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b Department of Pediatrics   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; PROTEOME;

AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MONOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN URINE LEVEL; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYNTAX SCORE; TANDEM MASS SPECTROMETRY; CASE CONTROL STUDY; INFLAMMATION; METABOLISM; PROCEDURES; URINE;

AGED; ANTIGENS, CD14; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; MONOCYTES; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84922592206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117169     Document Type: Article

References (47)

1. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695. PMID: 15843671
2. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, et al. (1995) Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 92: 8264-8268. PMID: 7667279
3. Zakynthinos E, Pappa N (2009) Inflammatory biomarkers in coronary artery disease. J Cardiol 53: 317-333. doi: 10.1016/j.jjcc.2008.12.007 PMID: 19477372
4. Afkarian M, Bhasin M, Dillon ST, Guerrero MC, Nelson RG, et al. (2010) Optimizing a proteomics platform for urine biomarker discovery. Mol Cell Proteomics 9: 2195-2204. doi: 10.1074/mcp.M110. 000992 PMID: 20511394
5. Good DM, Zurbig P, Argiles A, Bauer HW, Behrens G, et al. (2010) Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 9: 2424-2437. doi: 10. 1074/mcp.M110.001917 PMID: 20616184
6. Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, et al. (2009) Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis. Mol Cell Proteomics 8: 2296-2307. doi: 10.1074/mcp. M800529-MCP200 PMID: 19564150
7. Chiou SH, Wu CY (2011) Clinical proteomics: current status, challenges, and future perspectives. Kaohsiung J Med Sci 27: 1-14. doi: 10.1016/j.kjms.2010.12.001 PMID: 21329886
8. MacCoss MJ, McDonald WH, Saraf A, Sadygov R, Clark JM, et al. (2002) Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci U S A 99: 7900-7905. PMID: 12060738
9. Huang CH, Chiou SH (2014) Clinical proteomics identifies potential biomarkers in for gastrointestinal diseases. World J Gastroenterol 20: 1529-1536. doi: 10.3748/wjg.v20.i6.1529 PMID: 24587628
10. Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, et al. (2001) Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292: 929-934. PMID: 11340206
11. Kolch W, Neususs C, Pelzing M, Mischak H (2005) Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev 24: 959-977. PMID: 15747373
12. Huang CH, Chuang MH, Lo WL, Wu MS, Wu YH, et al. (2011) Alkylhydroperoxide reductase of Helicobacter pylori as a biomarker for gastric patients with different pathological manifestations. Biochimie 93: 1115-1123. doi: 10.1016/j.biochi.2011.03.008 PMID: 21440595
13. Huang CH, Chiou SH (2011) Proteomic analysis of upregulated proteins in Helicobacter pylori under oxidative stress induced by hydrogen peroxide. Kaohsiung J Med Sci 27: 544-553. doi: 10.1016/j. kjms.2011.06.019 PMID: 22208537
14. Huang CH, Wang YT, Tsai CF, Chen YJ, Lee JS, et al. (2011) Phosphoproteomics characterization of novel phosphorylated sites of lens proteins from normal and cataractous human eye lenses. Mol Vis 17: 186-198. PMID: 21264232
15. Huang CH, Lee IL, Yeh IJ, Liao JH, Ni CL, et al. (2010) Upregulation of a non-heme iron-containing ferritin with dual ferroxidase and DNA-binding activities in Helicobacter pylori under acid stress. J Biochem 147: 535-543. doi: 10.1093/jb/mvp200 PMID: 19959503
16. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, et al. (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1: 219-227. PMID: 19758907
17. Frangogiannis NG (2008) The immune system and cardiac repair. Pharmacol Res 58: 88-111. doi: 10. 1016/j.phrs.2008.06.007 PMID: 18620057
18. Nahrendorf M, Pittet MJ, Swirski FK (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121: 2437-2445. doi: 10.1161/CIRCULATIONAHA.109.916346 PMID: 20530020
19. van der Laan AM, Hirsch A, Robbers LF, Nijveldt R, Lommerse I, et al. (2012) A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with STsegment elevation myocardial infarction: monocytes and myocardial infarction. Am Heart J 163: 57- 65 e52. doi: 10.1016/j.ahj.2011.09.002 PMID: 22172437
20. Koenig W, Khuseyinova N, Hoffmann MM, Marz W, Frohlich M, et al. (2002) CD14 C(-260)->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 40: 34-42. PMID: 12103253
21. LiaoW(1996) Endotoxin: possible roles in initiation and development of atherosclerosis. J Lab Clin Med 128: 452-460. PMID: 8900288
22. Bhagat K, Moss R, Collier J, Vallance P (1996) Endothelial "stunning" following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res 32: 822-829. PMID: 8944812
23. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433. PMID: 1698311
24. Schumann RR, Rietschel ET, Loppnow H (1994) The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol 183: 279-297. PMID: 7541105
25. Pugin J, Kravchenko VV, Lee JD, Kline L, Ulevitch RJ, et al. (1998) Cell activation mediated by glycosylphosphatidylinositol-anchored or transmembrane forms of CD14. Infect Immun 66: 1174-1180. PMID: 9488411
26. Schroder NW, Opitz B, Lamping N, Michelsen KS, Zahringer U, et al. (2000) Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J Immunol 165: 2683-2693. PMID: 10946299
27. Roy S, Karmakar M, Pearlman E (2014) CD14 Mediates Toll-like Receptor 4 (TLR4) Endocytosis and Spleen Tyrosine Kinase (Syk) and Interferon Regulatory Transcription Factor 3 (IRF3) Activation in Epithelial Cells and Impairs Neutrophil Infiltration and Pseudomonas aeruginosa Killing in Vivo. J Biol Chem 289: 1174-1182. doi: 10.1074/jbc.M113.523167 PMID: 24275652
28. Estruch M, Bancells C, Beloki L, Sanchez-Quesada JL, Ordonez-Llanos J, et al. (2013) CD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytes. Atherosclerosis 229: 356-362. doi: 10.1016/j.atherosclerosis.2013.05.011 PMID: 23880187
29. Nair A, Kanda V, Bush-Joseph C, Verma N, Chubinskaya S, et al. (2012) Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and tolllike receptor 2 ligands via soluble CD14. Arthritis Rheum 64: 2268-2277. doi: 10.1002/art.34495 PMID: 22492243
30. Takeshita S, Nakatani K, Tsujimoto H, Kawamura Y, Kawase H, et al. (2000) Increased levels of circulating soluble CD14 in Kawasaki disease. Clin Exp Immunol 119: 376-381. PMID: 10632678
31. Wuthrich B, Kagi MK, Joller-Jemelka H (1992) Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 284: 339-342. PMID: 1284103
32. Horneff G, Sack U, Kalden JR, Emmrich F, Burmester GR (1993) Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 91: 207-213. PMID: 8443972
33. Yu S, Nakashima N, Xu BH, Matsuda T, Izumihara A, et al. (1998) Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatol Int 17: 237-243. PMID: 9592864
34. Nockher WA, Wigand R, SchoeppeW, Scherberich JE (1994) Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol 96: 15-19. PMID: 7512005
35. Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, et al. (2004) CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 92: 419-424. PMID: 15269840
36. Bazil V, Strominger JL (1991) Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147: 1567-1574. PMID: 1880416
37. Stelter F, Pfister M, Bernheiden M, Jack RS, Bufler P, et al. (1996) The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur J Biochem 236: 457-464. PMID: 8612616
38. Su GL, Dorko K, Strom SC, Nussler AK, Wang SC (1999) CD14 expression and production by human hepatocytes. J Hepatol 31: 435-442. PMID: 10488701
39. Inoue T, Eguchi Y, Matsumoto T, Kijima Y, Kato Y, et al. (2008) Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis 201: 385-391. doi: 10.1016/j.atherosclerosis.2008.03.010 PMID: 18436228
40. de Queiroz Mello AP, da Silva IT, Oliveira AS, Nunes VS, Abdalla DS, et al. (2010) Electronegative lowdensity lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk. Lipids 45: 619-625. doi: 10.1007/s11745-010-3439-7 PMID: 20574778
41. Greco TP, Conti-Kelly AM, Anthony JR, Greco T., Doyle R, et al. (2010) Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes. Am J Clin Pathol 133: 737-743. doi: 10.1309/ AJCP88WVRDRDFBAS PMID: 20395520
42. Harsimran K, Singh AA, Guruvinder S, Sharda S, Vasudha S (2009) Plasma monocyte chemoattractant protein-1 as risk marker in type 2 diabetes mellitus and coronary artery disease in North Indians. Diab Vasc Dis Res 6: 288-290. doi: 10.1177/1479164109346364 PMID: 20368224
43. Niccoli G, Ferrante G, Cosentino N, Conte M, Belloni F, et al. (2010) Eosinophil cationic protein: A new biomarker of coronary atherosclerosis. Atherosclerosis 211: 606-611. doi: 10.1016/j.atherosclerosis. 2010.02.038 PMID: 20307883
44. Laufer EM, Mingels AM, Winkens MH, Joosen IA, Schellings MW, et al. (2010) The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol 30: 1269-1275. doi: 10.1161/ATVBAHA.109.200394 PMID: 20299689
45. Schroecksnadel K, Grammer TB, Boehm BO, Marz W, Fuchs D (2010) Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers. Thromb Haemost 103: 926-935. doi: 10.1160/TH09-07-0422 PMID: 20216983
46. Sonmez K, Eskisar AO, Demir D, Yazicioglu MV, Mutlu B, et al. (2006) Increased urinary albumin excretion rates can be a marker of coexisting coronary artery disease in patients with peripheral arterial disease. Angiology 57: 15-20. PMID: 16444452
47. Fitzsimmons PJ, Forough R, Lawrence ME, Gantt DS, Rajab MH, et al. (2007) Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease. Atherosclerosis 194: 196-203. PMID: 16942771